Publications by authors named "B P Chowdhary"
Article Synopsis
- A neonate with a mass in the coccygeal area experienced severe abdominal issues on day 4, including distension and bloody stomach contents, leading to a diagnosis of necrotizing enterocolitis.
- Imaging indicated the coccygeal mass was a Type II sacrococcygeal teratoma, which likely caused bowel compression and contributed to the gut's digestive issues.
- After the mass was surgically removed, the neonate showed no further symptoms, highlighting the need for careful observation in similar cases to catch potential complications early.
Cervical cancer is among the most commonly diagnosed cancers in pregnancy and for some patients, abortion may be desired or recommended. The Dobbs v Jackson decision has the potential to limit choice while exacerbating disparities in cervical cancer care. We highlight the necessity of employing a reproductive justice framework to both clinical care and research for cervical cancer care in pregnancy to increase access to reproductive choice and to address inequities.
View Article and Find Full Text PDFPatch testing with expired Indian patch test kits: Results of a pilot study.
Indian J Dermatol Venereol Leprol
March 2022
Background: The reliability of patch testing with expired Indian standard patch test kits has been not evaluated before.
Methods: Thirty adults (men:women 25:5) with allergic contact dermatitis were divided into three groups of ten patients each for patch testing by Finn chamber® method using Indian standard patch test kits having expiry in 2016, 2015 and 2014. The results were compared with those from a new kit with 2018 expiry.
Association of Psoriasis with Autoimmune Disorders: Results of a Pilot Study.
Indian Dermatol Online J
September 2020
Background: Association of psoriasis with other autoimmune diseases remains an ongoing research subject.
Objectives: To investigate the association of psoriasis with other autoimmune disorders.
Materials And Methods: We studied 80 (M: F 57:23) psoriasis patients aged 13-75 years for concurrent autoimmune disorders.